INTEGER HOLDINGS CORPORATION Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
INTEGER HOLDINGS CORPORATION (ITGR) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 28.45 thousand shares for the 12-month period ending 2018-12-28, per its 10-K filed 2019-02-22.
Discontinued › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2019-02-22
- INTEGER HOLDINGS CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2018-12-28 was 0.00 shares.
- INTEGER HOLDINGS CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2018-09-28 was 0.00 shares, a 100.00% decline year-over-year.
- INTEGER HOLDINGS CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2018-06-29 was 0.00 shares, a 100.00% decline year-over-year.
- INTEGER HOLDINGS CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2018-03-30 was 28.45K shares, a 15.43% decline year-over-year.
- INTEGER HOLDINGS CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2018 was 28.45K shares, a 77.25% decline from fiscal 2017.
- INTEGER HOLDINGS CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2017 was 125.02K shares, a 60.52% decline from fiscal 2016.
- INTEGER HOLDINGS CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2016 was 316.68K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2018-12-28 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | 0.00 shares derived: sum of 2 quarters · filed 2019-02-22 | 0.00 shares derived: sum of 3 quarters · filed 2019-02-22 | 28.45K shares 10-K · filed 2019-02-22 |
| 2018-09-28 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02 | 0.00 shares derived: sum of 2 quarters · filed 2018-11-02 | 28.45K shares 10-Q · filed 2018-11-02 | 28.45K shares derived: sum of 4 quarters · filed 2018-11-02 |
| 2018-06-29 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | 28.45K shares 10-Q · filed 2018-08-03 | 28.45K shares derived: sum of 3 quarters · filed 2018-08-03 | 96.06K shares derived: sum of 4 quarters · filed 2018-08-03 |
| 2018-03-30 | 28.45K shares 10-Q · filed 2018-05-04 | 28.45K shares derived: sum of 2 quarters · filed 2018-05-04 | 96.06K shares derived: sum of 3 quarters · filed 2018-05-04 | 119.83K shares derived: sum of 4 quarters · filed 2018-05-04 |
| 2017-12-29 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | 67.61K shares derived: sum of 2 quarters · filed 2018-02-22 | 91.38K shares derived: sum of 3 quarters · filed 2018-02-22 | 125.02K shares 10-K · filed 2018-02-22 |
| 2017-09-29 | 67.61K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-30 | 91.38K shares derived: sum of 2 quarters · filed 2017-10-30 | 125.02K shares 10-Q · filed 2017-10-30 | 196.26K shares derived: sum of 4 quarters · filed 2017-10-30 |
| 2017-06-30 | 23.77K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | 57.41K shares 10-Q · filed 2017-08-02 | 128.65K shares derived: sum of 3 quarters · filed 2017-08-02 | 138.23K shares derived: sum of 4 quarters · filed 2017-08-02 |
| 2017-03-31 | 33.64K shares 10-Q · filed 2017-05-09 | 104.88K shares derived: sum of 2 quarters · filed 2017-05-09 | 114.46K shares derived: sum of 3 quarters · filed 2017-05-09 | 197.77K shares derived: sum of 4 quarters · filed 2017-05-09 |
| 2016-12-30 | 71.24K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | 80.82K shares derived: sum of 2 quarters · filed 2017-02-28 | 164.13K shares derived: sum of 3 quarters · filed 2017-02-28 | 316.68K shares 10-K · filed 2017-02-28 |
| 2016-09-30 | 9.58K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | 92.89K shares derived: sum of 2 quarters · filed 2016-11-08 | 245.44K shares 10-Q · filed 2016-11-08 | |
| 2016-07-01 | 83.31K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | 235.86K shares 10-Q · filed 2016-08-09 | ||
| 2016-04-01 | 152.55K shares 10-Q · filed 2016-05-10 | |||
| 2015-10-02 | 301.55K shares 10-Q · filed 2015-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |